Tuberculous Scleritis and Multidrug Resistance-Reference-Cited by-同舟云学术

Tuberculous Scleritis and Multidrug Resistance

Published:2021-01-08 Issue: Volume: Page:1-10
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Agarwal Mamta¹,Patnaik Gazal²,Agarwal Shweta³,Iyer Geetha³,Anand A. R.⁴,Ar Gayathri⁵,Biswas Jyotirmay⁶,Zierhut Manfred⁷

Affiliation:

1. Uveitis & Cornea Services, Medical Research Foundation, Sankara Nethralaya, Chennai, India

2. Uveitis Services, Medical Research Foundation, Sankara Nethralaya, Chennai, India

3. CJ Shah Cornea Services, Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, Medical Research Foundation, Sankara Nethralaya, Chennai, India

4. L & T Microbiology Research Centre, Vision Research Foundation, Sankara Nethralaya, Chennai, India

5. Pulmonologist, Apollo Hospitals, Chennai, Tamil Nadu, India

6. Uveitis & Ocular Pathology Department, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India

7. Department of Ophthalmology, University of Tubingen, Tubingen, Germany

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2020.1853176

Reference43 articles.

1. World Health Organization. Global tuberculosis report 2019 http://www.who.int.tb/publications/global_report/en

2. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India

3. Ocular Tuberculosis: Anterior Segment

4. Changing Patterns of Uveitis

5. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectious Scleritis – Clinical Characteristics, Causative Factors, and Treatment Outcomes in an Indian Population;Ocular Immunology and Inflammation;2024-08-08

2. Necrotizing Scleritis: A Review;Ocular Immunology and Inflammation;2023-06-06

3. Intravitreal Anti-Vascular Endothelial Growth Factor and Moxifloxacin for Treatment of Tubercular Choroidal Granuloma and Sub retinal Abscess;Ocular Immunology and Inflammation;2023-01-13

4. Adjunctive Intravitreal Anti-vascular Endothelial Growth Factor and Moxifloxacin Therapy in Management of Intraocular Tubercular Granulomas;Ocular Immunology and Inflammation;2021-12-17